J. O. Rosa, Udofia Cynthia Emmanuel, Nwanosike Ahamefula Okeosisi
{"title":"抗癌植物小叶Rutidea parviflora的植物化学筛选及体内抗炎活性研究","authors":"J. O. Rosa, Udofia Cynthia Emmanuel, Nwanosike Ahamefula Okeosisi","doi":"10.31487/J.COR.2020.10.02","DOIUrl":null,"url":null,"abstract":"The rapid development of malignant cancers is characterized by inflammation, which poses a significant\ndrawback in cancer therapy. Both cancer and inflammation operate on very similar mechanisms involving\nangiogenesis and cell proliferation. Currently, cancer-intrinsic inflammations have been shown to promote\ncancer progression and hinder apoptosis of cancerous cells. Thus, an effective strategy for chemoprevention\nand therapy would involve the control of inflammation. This research work aims to investigate the antiinflammatory activity of the extracts of the root bark of Rutidea parviflora (Rubiaceae), a plant I previously\nreported for anti-ovarian cancer activities and the isolation of palmatine; an anti-cancer compound and a\nsecond compound; urs-12-ene-24-oic acid, 3-oxo, methyl ester. This plant is renowned for its antiinflammatory properties amongst locals in Delta state, Nigeria, which has necessitated this present research.\nOrganic and aqueous extracts were obtained from the pulverized root bark by use of the America national\ncancer institute protocol (NCI). The organic extract was partitioned sequentially in increasing order of\npolarity with n-hexane, ethyl acetate, n-butanol and distilled water to obtain four fractions. Phytochemical\nscreening was done using standard procedures. Results from the phytochemical screening indicated the\npresence of alkaloids, flavonoids, saponins, tannins, glycosides and carbohydrates. Anti-inflammatory\ninvestigations of the extracts and fractions were carried out by the induction of inflammation. The animals\nwere grouped into 12 test groups and 2 control groups with 6 rats per group. Egg albumin (0.1 ml) was\nadministered sub-plantarly followed by treatment. Group A received a dose of 200 mg/kg of the plant\nextracts and Group B received a dose of 400 mg/kg of the plant extracts. Group C (positive control) received\nindomethacin (10 mg/kg), while Group D (negative control) received 1 ml of normal saline. Statistical\nanalysis showed significance against the negative control indicated by P<0.05 for extracts and fractions.\nWhile for the fourth hour post induction of inflammation; the activities of the Group B organic extract, ethyl\nacetate and n-butanol fractions were comparable with indomethacin indicating that the plant possess\nsignificant anti-inflammatory activity and warrants further anti-inflammatory studies.","PeriodicalId":10487,"journal":{"name":"Clinical Oncology and Research","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Phytochemical Screening and In Vivo Anti-Inflammatory Activities of Anti-Cancer Plant: Rutidea parviflora (Rubiaceae)\",\"authors\":\"J. O. Rosa, Udofia Cynthia Emmanuel, Nwanosike Ahamefula Okeosisi\",\"doi\":\"10.31487/J.COR.2020.10.02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The rapid development of malignant cancers is characterized by inflammation, which poses a significant\\ndrawback in cancer therapy. Both cancer and inflammation operate on very similar mechanisms involving\\nangiogenesis and cell proliferation. Currently, cancer-intrinsic inflammations have been shown to promote\\ncancer progression and hinder apoptosis of cancerous cells. Thus, an effective strategy for chemoprevention\\nand therapy would involve the control of inflammation. This research work aims to investigate the antiinflammatory activity of the extracts of the root bark of Rutidea parviflora (Rubiaceae), a plant I previously\\nreported for anti-ovarian cancer activities and the isolation of palmatine; an anti-cancer compound and a\\nsecond compound; urs-12-ene-24-oic acid, 3-oxo, methyl ester. This plant is renowned for its antiinflammatory properties amongst locals in Delta state, Nigeria, which has necessitated this present research.\\nOrganic and aqueous extracts were obtained from the pulverized root bark by use of the America national\\ncancer institute protocol (NCI). The organic extract was partitioned sequentially in increasing order of\\npolarity with n-hexane, ethyl acetate, n-butanol and distilled water to obtain four fractions. Phytochemical\\nscreening was done using standard procedures. Results from the phytochemical screening indicated the\\npresence of alkaloids, flavonoids, saponins, tannins, glycosides and carbohydrates. Anti-inflammatory\\ninvestigations of the extracts and fractions were carried out by the induction of inflammation. The animals\\nwere grouped into 12 test groups and 2 control groups with 6 rats per group. Egg albumin (0.1 ml) was\\nadministered sub-plantarly followed by treatment. Group A received a dose of 200 mg/kg of the plant\\nextracts and Group B received a dose of 400 mg/kg of the plant extracts. Group C (positive control) received\\nindomethacin (10 mg/kg), while Group D (negative control) received 1 ml of normal saline. Statistical\\nanalysis showed significance against the negative control indicated by P<0.05 for extracts and fractions.\\nWhile for the fourth hour post induction of inflammation; the activities of the Group B organic extract, ethyl\\nacetate and n-butanol fractions were comparable with indomethacin indicating that the plant possess\\nsignificant anti-inflammatory activity and warrants further anti-inflammatory studies.\",\"PeriodicalId\":10487,\"journal\":{\"name\":\"Clinical Oncology and Research\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Oncology and Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31487/J.COR.2020.10.02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Oncology and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31487/J.COR.2020.10.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Phytochemical Screening and In Vivo Anti-Inflammatory Activities of Anti-Cancer Plant: Rutidea parviflora (Rubiaceae)
The rapid development of malignant cancers is characterized by inflammation, which poses a significant
drawback in cancer therapy. Both cancer and inflammation operate on very similar mechanisms involving
angiogenesis and cell proliferation. Currently, cancer-intrinsic inflammations have been shown to promote
cancer progression and hinder apoptosis of cancerous cells. Thus, an effective strategy for chemoprevention
and therapy would involve the control of inflammation. This research work aims to investigate the antiinflammatory activity of the extracts of the root bark of Rutidea parviflora (Rubiaceae), a plant I previously
reported for anti-ovarian cancer activities and the isolation of palmatine; an anti-cancer compound and a
second compound; urs-12-ene-24-oic acid, 3-oxo, methyl ester. This plant is renowned for its antiinflammatory properties amongst locals in Delta state, Nigeria, which has necessitated this present research.
Organic and aqueous extracts were obtained from the pulverized root bark by use of the America national
cancer institute protocol (NCI). The organic extract was partitioned sequentially in increasing order of
polarity with n-hexane, ethyl acetate, n-butanol and distilled water to obtain four fractions. Phytochemical
screening was done using standard procedures. Results from the phytochemical screening indicated the
presence of alkaloids, flavonoids, saponins, tannins, glycosides and carbohydrates. Anti-inflammatory
investigations of the extracts and fractions were carried out by the induction of inflammation. The animals
were grouped into 12 test groups and 2 control groups with 6 rats per group. Egg albumin (0.1 ml) was
administered sub-plantarly followed by treatment. Group A received a dose of 200 mg/kg of the plant
extracts and Group B received a dose of 400 mg/kg of the plant extracts. Group C (positive control) received
indomethacin (10 mg/kg), while Group D (negative control) received 1 ml of normal saline. Statistical
analysis showed significance against the negative control indicated by P<0.05 for extracts and fractions.
While for the fourth hour post induction of inflammation; the activities of the Group B organic extract, ethyl
acetate and n-butanol fractions were comparable with indomethacin indicating that the plant possess
significant anti-inflammatory activity and warrants further anti-inflammatory studies.